HansBiomed Statistics

Total Valuation

HansBiomed has a market cap or net worth of KRW 366.23 billion. The enterprise value is 398.62 billion.

Market Cap	366.23B
Enterprise Value	398.62B

Important Dates

The next estimated earnings date is Friday, December 19, 2025.

Earnings Date	Dec 19, 2025
Ex-Dividend Date	n/a

Share Statistics

HansBiomed has 12.99 million shares outstanding. The number of shares has increased by 2.92% in one year.

Current Share Class	12.99M
Shares Outstanding	12.99M
Shares Change (YoY)	+2.92%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.98%
Owned by Institutions (%)	0.71%
Float	8.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	34.56
PS Ratio	4.28
PB Ratio	5.89
P/TBV Ratio	5.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 233.25, with an EV/FCF ratio of -108.68.

EV / Earnings	-39.99
EV / Sales	4.66
EV / EBITDA	233.25
EV / EBIT	n/a
EV / FCF	-108.68

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.69.

Current Ratio	1.05
Quick Ratio	0.55
Debt / Equity	0.69
Debt / EBITDA	8.12
Debt / FCF	-11.66
Interest Coverage	-0.00

Financial Efficiency

Return on equity (ROE) is -15.31% and return on invested capital (ROIC) is -0.00%.

Return on Equity (ROE)	-15.31%
Return on Assets (ROA)	-0.00%
Return on Invested Capital (ROIC)	-0.00%
Return on Capital Employed (ROCE)	-0.00%
Revenue Per Employee	308.94M
Profits Per Employee	-35.98M
Employee Count	277
Asset Turnover	0.67
Inventory Turnover	1.19

Taxes

In the past 12 months, HansBiomed has paid 1.92 billion in taxes.

Income Tax	1.92B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +266.23% in the last 52 weeks. The beta is 2.10, so HansBiomed's price volatility has been higher than the market average.

Beta (5Y)	2.10
52-Week Price Change	+266.23%
50-Day Moving Average	26,732.40
200-Day Moving Average	12,900.80
Relative Strength Index (RSI)	47.04
Average Volume (20 Days)	518,376

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HansBiomed had revenue of KRW 85.58 billion and -9.97 billion in losses. Loss per share was -768.17.

Revenue	85.58B
Gross Profit	53.59B
Operating Income	-314,530
Pretax Income	-8.52B
Net Income	-9.97B
EBITDA	5.26B
EBIT	-314,530
Loss Per Share	-768.17

Full Income Statement

Balance Sheet

The company has 10.21 billion in cash and 42.76 billion in debt, giving a net cash position of -32.54 billion or -2,505.69 per share.

Cash & Cash Equivalents	10.21B
Total Debt	42.76B
Net Cash	-32.54B
Net Cash Per Share	-2,505.69
Equity (Book Value)	62.23B
Book Value Per Share	4,803.56
Working Capital	2.69B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.64 billion and capital expenditures -2.03 billion, giving a free cash flow of -3.67 billion.

Operating Cash Flow	-1.64B
Capital Expenditures	-2.03B
Free Cash Flow	-3.67B
FCF Per Share	-282.42

Full Cash Flow Statement

Margins

Gross margin is 62.62%, with operating and profit margins of -0.00% and -11.65%.

Gross Margin	62.62%
Operating Margin	-0.00%
Pretax Margin	-9.95%
Profit Margin	-11.65%
EBITDA Margin	6.15%
EBIT Margin	-0.00%
FCF Margin	n/a

Dividends & Yields

HansBiomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.92%
Shareholder Yield	-2.92%
Earnings Yield	-2.72%
FCF Yield	-1.00%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HansBiomed has an Altman Z-Score of 1.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.49
Piotroski F-Score	3